YU42439B - Process for obtaining pyridoxine derivatives - Google Patents

Process for obtaining pyridoxine derivatives

Info

Publication number
YU42439B
YU42439B YU2519/81A YU251981A YU42439B YU 42439 B YU42439 B YU 42439B YU 2519/81 A YU2519/81 A YU 2519/81A YU 251981 A YU251981 A YU 251981A YU 42439 B YU42439 B YU 42439B
Authority
YU
Yugoslavia
Prior art keywords
obtaining
pyridoxine derivatives
pyridoxine
derivatives
obtaining pyridoxine
Prior art date
Application number
YU2519/81A
Other languages
English (en)
Other versions
YU251981A (en
Inventor
A Reiner
Original Assignee
D & D Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D & D Srl filed Critical D & D Srl
Publication of YU251981A publication Critical patent/YU251981A/xx
Publication of YU42439B publication Critical patent/YU42439B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
YU2519/81A 1980-10-21 1981-10-21 Process for obtaining pyridoxine derivatives YU42439B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT25473/80A IT1133963B (it) 1980-10-21 1980-10-21 Derivati piridossinici ad attivita' terapeutica,procedimento per la loro preparazione e relative composizioni farmaceutiche

Publications (2)

Publication Number Publication Date
YU251981A YU251981A (en) 1984-02-29
YU42439B true YU42439B (en) 1988-08-31

Family

ID=11216796

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2519/81A YU42439B (en) 1980-10-21 1981-10-21 Process for obtaining pyridoxine derivatives

Country Status (17)

Country Link
US (1) US4412996A (cs)
EP (1) EP0050385B1 (cs)
JP (1) JPS5795962A (cs)
AR (1) AR230747A1 (cs)
AT (1) ATE17850T1 (cs)
AU (1) AU551422B2 (cs)
BE (1) BE890798A (cs)
CA (1) CA1190922A (cs)
DE (1) DE3173724D1 (cs)
DK (1) DK462181A (cs)
ES (1) ES506375A0 (cs)
FR (1) FR2492375B1 (cs)
IT (1) IT1133963B (cs)
MX (1) MX154715A (cs)
NO (1) NO159855C (cs)
PT (1) PT73844B (cs)
YU (1) YU42439B (cs)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717636A (en) * 1970-01-21 1973-02-20 A Esanu Salts of pyridoxine mono-esters
ES411535A1 (es) * 1973-02-12 1976-01-01 Farmabion S A Un procedimiento para la preparacion de esteres del 1-(p- cloro-benzoil)-5-metoxi-2 metilindol-3-acetico, con feno- les.
SE428560B (sv) * 1974-07-22 1983-07-11 Merck & Co Inc Forfarande for framstellning av 5-(2,4-difluorofenyl)salicylsyra.
JPS52156862A (en) * 1976-06-22 1977-12-27 Hisamitsu Pharmaceut Co Inc Novel indoleacetic acid ester derivatives
CH601228A5 (en) * 1977-06-17 1978-06-30 Hisamitsu Pharmaceutical Co Antiinflammatory indomethacin esters active topically and orally
IT1097601B (it) * 1978-07-31 1985-08-31 Crinos Industria Farmaco Derivati della piridosina ad attivita' farmacologica
US4233304A (en) * 1978-07-31 1980-11-11 Crinos Industria Farmacobiologica S.P.A. Pyridoxine derivatives

Also Published As

Publication number Publication date
EP0050385A1 (en) 1982-04-28
JPH0343268B2 (cs) 1991-07-01
ATE17850T1 (de) 1986-02-15
JPS5795962A (en) 1982-06-15
AR230747A1 (es) 1984-06-29
IT1133963B (it) 1986-07-24
IT8025473A0 (it) 1980-10-21
MX154715A (es) 1987-12-03
YU251981A (en) 1984-02-29
EP0050385B1 (en) 1986-02-05
FR2492375A1 (fr) 1982-04-23
NO159855C (no) 1989-02-15
AU551422B2 (en) 1986-05-01
CA1190922A (en) 1985-07-23
NO159855B (no) 1988-11-07
US4412996A (en) 1983-11-01
NO813537L (no) 1982-04-22
FR2492375B1 (fr) 1986-10-10
DE3173724D1 (en) 1986-03-20
PT73844A (en) 1981-11-01
ES8207142A1 (es) 1982-09-01
AU7662281A (en) 1982-09-09
DK462181A (da) 1982-04-22
ES506375A0 (es) 1982-09-01
PT73844B (en) 1983-01-25
BE890798A (fr) 1982-02-15

Similar Documents

Publication Publication Date Title
YU221681A (en) Process for obtaining n-arylbenzamide derivatives
YU43051B (en) Process for preparing 1-sulfo-2-oxo-azetidine derivatives
YU227181A (en) Process for obtaining 3-aryl-5-isothiazole derivatives
YU97583A (en) Process for obtaining new piperidine derivatives
PT73186B (en) Process for preparing pyrazolopyrydazine derivatives
YU126281A (en) Process for obtaining new pyridoxine derivatives
YU98081A (en) Process for obtaining imidosulfamide derivatives
DE3160156D1 (en) Process for preparing vinylphosphonic-acid derivatives
YU42592B (en) Process for preparing 3-amino-propoxyphenyl derivatives
YU81181A (en) Process for obtaining substituted derivatives
PT74674B (en) Process for preparing pyridine derivatives
PT73113B (en) Process for preparing substituted phenoxy-aminopropanol derivatives
PT74153A (en) Process for preparing oxadiazolopyrimidine derivatives
YU85181A (en) Process for obtaining new ergoline derivatives
YU252981A (en) Process for obtaining 11-dodecene-1-yl derivatives
YU159481A (en) Process for preparing dibenzindole derivatives
YU42413B (en) Process for obtaining dephenylether derivatives
SG65486G (en) Process for preparing 16-hydroxy-17-aminoprepnane derivatives
PT73457A (en) Process for preparing heteroprostaglandin derivatives
YU246381A (en) Process for obtaining cephalexine derivatives
DE3164471D1 (en) Process for preparing pyridine derivatives
YU182381A (en) Process for obtaining new ergoline derivatives
YU42439B (en) Process for obtaining pyridoxine derivatives
PH17891A (en) Process for preparing pyridine derivatives
YU44817B (en) Process for obtaining l-asparagyl-d-amino-acid derivatives